During the past decade, Riverside Methodist Hospital Cancer Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 72 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riverside Methodist Hospital Cancer Care" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 44 trials, followed by "SWOG Cancer Research Network" with 39 trials sponsored, "Gynecologic Oncology Group" with 15 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored and "Radiation Therapy Oncology Group" with 11 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverside Methodist Hospital Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 131 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator and "Eastern Cooperative Oncology Group" with 7 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Riverside Methodist Hospital Cancer Care" are "Breast Cancer" (26 trials), "Lung Cancer" (15 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (15 trials), "Lymphoma" (11 trials) and "Leukemia" (9 trials). Many other conditions were trialed in "Riverside Methodist Hospital Cancer Care" in a lesser frequency.

Most popular intervention types in "Riverside Methodist Hospital Cancer Care" are "Drug" (97 trials), "Other" (42 trials), "Biological" (34 trials), "Radiation" (23 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (25 trials), "bevacizumab" (12 trials), "cisplatin" (11 trials), "radiation therapy" (11 trials) and "cyclophosphamide" (8 trials). Other intervention names were less common.

The vast majority of trials in "Riverside Methodist Hospital Cancer Care" are 94 trials for "All" genders, 33 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Riverside Methodist Hospital Cancer Care". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 113 completed trials in Riverside Methodist Hospital Cancer Care, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Riverside Methodist Hospital Cancer Care, 3 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".